ArticleJournal of the Canadian Association of Gastroenterology2025
Enhancing efficiency in ESD: a comparative analysis of ERBE VIO3 and 300d electrosurgical units.
Article in Journal of the Canadian Association of Gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Electrosurgical units (ESUs) are essential for tissue dissection hemostasis during ESD. The ERBE VIO 3, enables rapid setting changes, facilitating the swift application of vessel sealing current. Additionally, features such as PreciseSect mode allow dynamic modulation frequency adjustment, making it suitable for submucosal dissection and vessel management. Our comparison of the ERBE VIO3 and 300d aims to assess whether these functionalities enhance the ESD experience. Methods: From 2021 to 2024, 88 patients undergoing ESD for colorectal lesions were identified from a prospectively maintained database. Lesions were categorized based on the ESU utilized. Results: Eighty-eight procedures were identified. Forty-four (50.0%) procedures were performed using VIO 3 and 44 (50.0%) using VIO 300d. 40 (45.5%) lesions were colonic and 48 (54.5%) rectal. Median lesion diameter was 4.5 cm. Lesions in the VIO3 group were significantly larger ( Conclusions: The VIO 3 significantly decreased reliance on coagulation graspers, particularly in addressing arterial bleeding. This holds the potential to enhance procedural efficiency, reduce bleeding, and lower costs associated with coagulation graspers usage.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.